These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4714677)

  • 1. Comparison of 9 -THC, LSD-25 and scopolamine on non-spatial single alternation performance in the runway.
    Miller LL; Drew WG; Wikler A
    Psychopharmacologia; 1973; 28(1):1-11. PubMed ID: 4714677
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of delta9-THC, LSD-25 and scopolamine on continuous, spontaneous alternation in the Y-maze.
    Drew WG; Miller LL; Baugh EL
    Psychopharmacologia; 1973; 32(2):171-82. PubMed ID: 4753532
    [No Abstract]   [Full Text] [Related]  

  • 3. A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats.
    Cameron OG; Appel JB
    Psychopharmacologia; 1973; 33(2):117-34. PubMed ID: 4272898
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of cross-tolerance in rats among (-)delta9-trans-tetrahydrocannabinol(delta9-THC), cannabis extract, mescaline and lysergic acid diethylamide (LSD-25).
    Teresa M; Silva A; Carlini EA; Claussen U; Korte F
    Psychopharmacologia; 1968; 13(4):332-40. PubMed ID: 5722169
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of delta 9-tetrahydrocannabinol and LSD on the acquisition of an active avoidance response in the rat.
    Waser PG; Martin A; Heer-Carcano L
    Psychopharmacologia; 1976 Apr; 46(3):249-54. PubMed ID: 951460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacological analysis of processes underlying differential responding: a review and further experiments with scopolamine, amphetamine, lysergic acid diethylamide (LSD-25), chlordiazepoxide, physostigmine, and chlorpromazine.
    Frontali M; Amorico L; De Acetis L; Bignami G
    Behav Biol; 1976 Sep; 18(1):1-74. PubMed ID: 791242
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of cannabis extract, 9 -tetrahydrocannabinol and lysergic acid diethylamide on rat liver enzymes.
    Poddar MK; Ghosh JJ
    Biochem Pharmacol; 1972 Dec; 21(24):3301-3. PubMed ID: 4405370
    [No Abstract]   [Full Text] [Related]  

  • 8. Discriminative response control produced with hashish, tetrahydrocannabinols (delta 8-THC and delta 9-THC), and other drugs.
    Järbe TU; Henriksson BG
    Psychopharmacologia; 1974; 40(1):1-16. PubMed ID: 4445444
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of LSD-25 on activity level of the hooded rat.
    Slivka RM; Landis D; Mountjoy PT
    Psychol Rep; 1967 Feb; 20(1):158. PubMed ID: 6037778
    [No Abstract]   [Full Text] [Related]  

  • 10. Delta 9-tetrahydrocannabinol produced discrimination in pigeons.
    Henriksson BG; Johansson JO; Järbe TU
    Pharmacol Biochem Behav; 1975; 3(5):771-4. PubMed ID: 1208619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The behavior of worker and non-worker rats under the influence of (-) 9 -trans-tetrahydrocannabinol, chlorpromazine and amylobarbitone.
    Masur J; Märtz RM; Carlini EA
    Psychopharmacologia; 1972; 25(1):57-68. PubMed ID: 5038983
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of the stimulus effects of morphine and lysergic acid diethylamide (LSD).
    Hirschhorn ID; Rosecrans JA
    Pharmacol Biochem Behav; 1974 May; 2(3):361-6. PubMed ID: 4837907
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats].
    Loew DM; Depoortere H; Vigouret JM
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):394-5. PubMed ID: 4326420
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction of conditioned suppression: actions of morphine compared with those of amphetamine, pentobarbital, nalorphine, cocaine, LSD-25 and chlorpromazine.
    Hill HE; Bell EC; Wikler A
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):212-26. PubMed ID: 6030238
    [No Abstract]   [Full Text] [Related]  

  • 15. An analysis of some discriminative properties of d-amphetamine.
    Kuhn DM; Appel JB; Greenberg I
    Psychopharmacologia; 1974; 39(1):57-66. PubMed ID: 4138622
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of lysergic acid diethylamide (LSD) effects in pregnant rats.
    Bergen JR
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):313-9. PubMed ID: 4679854
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavioral tolerance to the effects of LSD in the rat.
    Commissaris RL; Lyness WH; Cordon JJ; Moore KE; Rech RH
    Subst Alcohol Actions Misuse; 1980; 1(2):203-7. PubMed ID: 7302781
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerance and limited cross-tolerance to the effects of N, N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) on food-rewarded bar pressing in the rat.
    Kovacic B; Domino EF
    J Pharmacol Exp Ther; 1976 Jun; 197(3):495-502. PubMed ID: 1064726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Action of lysergic acid diethylamide on the operant conditioning activity of rats].
    Molinengo L
    Arch Int Pharmacodyn Ther; 1965 Sep; 157(1):28-42. PubMed ID: 5885004
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of LSD on open field performance in rats.
    Dandiya PC; Gupta BD; Gupta ML; Patni SK
    Psychopharmacologia; 1969; 15(4):333-40. PubMed ID: 5352145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.